ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 890

Test of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) 29-Item Profile in a Large Cohort of Rheumatic Disease Patients

Patricia P. Katz1, Sofia Pedro2 and Kaleb Michaud3, 1Medicine, University of California, San Francisco, San Francisco, CA, 21035 N Emporia Ste 288, National Data Bank, Wichita, KS, 3University of Nebraska Medical Center and National Data Bank, Omaha, NE

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: measure and patient outcomes

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Exemplary Abstracts

Session Type: Abstract Submissions (ARHP)

Background/Purpose: Patient-reported outcomes are routinely used in rheumatology research and clinical care.  Yet, often outcomes cannot be compared across studies or diseases because a variety of measures are used in these assessments, and many important health domains are not assessed because of lack of measures or concerns about questionnaire burden.  Further, many “traditional” patient-reported outcomes measures are available only in English, which is an increasingly limiting factor.  The NIH Patient-Reported Outcomes Measurement Information System (PROMIS) consists of a group of patient-reported outcome measures that span a wide array of physical, social, and emotional health outcomes; are applicable across health conditions; and are available free of charge and in multiple languages.  A test of the PROMIS measures has not been undertaken in patients with RA, OA, or fibromyalgia.  This analysis presents an initial psychometric evaluation of PROMIS measures in a large cohort of these patients.

Methods:   Data were from a subset of respondents to a single administration of a questionnaire that included the PROMIS 29-item profile.  The sample included 528 individuals (RA: 323; OA: 109; fibromyalgia: 96).  Using short questionnaires, the PROMIS-29 assesses 7 of the PROMIS health domains:  Physical Function, Pain Interference, Fatigue, Depression, Anxiety, Sleep Disturbance, and Ability to Participate in Social Roles.  Each section was scored and converted to t-scores, with mean = 50 and SD = 10.  Analyses examined correlations of PROMIS measures with scales measuring related constructs (SF-36 subscales, Health Assessment Questionnaire [HAQ], and numeric rating scales for pain, fatigue, and sleep problems), for the total sample and within disease groups.  Analyses also examined ability of PROMIS measures to discriminate among levels of satisfaction with health.

Results: PROMIS scales exhibited moderate (r<0.7) correlations with most of the comparison measures, with some correlations slightly higher, indicating that similar constructs were being measured (Table 1).  Results were similar for each disease group.  All PROMIS scales discriminated among levels of satisfaction with health, yielding significant overall ANOVA results and significant non-parametric tests of trend (Table 2).

Conclusion:   These PROMIS short forms exhibited strong psychometric properties.  Use of PROMIS offers important expansions of current measures so that aspects of health, social functioning, and quality of life that are important to patients can be included without increasing questionnaire burden.  

Table 1.  Correlation of PROMIS Scales with Related Measures

 

PROMIS 29-Item Profile scales*

 

PF

PI

FAT

DEP

ANX

SLP

SocR

SF-36 Physical Function

0.83

 

 

 

 

 

 

SF-36 Role Physical

 

 

 

 

 

 

0.62

SF-36 Role Emotional

 

 

 

 

 

 

0.43

SF-36 Vitality

 

 

-0.77

 

 

 

 

SF-36 Bodily Pain

 

-0.73

 

 

 

 

 

SF-36 Mental Health

 

 

 

-0.69

-0.67

 

 

HAQ

-0.74

 

 

 

 

 

 

NRS-pain

 

0.62

 

 

 

 

 

NRS-fatigue

 

 

0.71

 

 

 

 

NRS-sleep

 

 

 

 

 

0.71

 

* For all PROMIS scales, higher scores reflect “more” of the construct being measured. E.g., Higher Physical Function scores reflect better functioning; higher Pain Interference scores reflect greater pain interference

PF = Physical Functioning; PI = Pain Interference; FAT = Fatigue; DEP = Depression; ANX = Anxiety; SLP = Sleep disturbance; SocR = Ability to Participation in Social Roles.

HAQ = Health Assessment Questionnaire

 

Table 2.  PROMIS 29-Profile Scores* by Levels of Satisfaction with Health

 

PROMIS 29-Item Profile scales*

Satisfaction with health:

PF

PI

FAT

DEP

ANX

SLP

SocRole

Very satisfied (n=61)

46.9

52.7

48.0

45.0

44.6

47.5

52.5

Somewhat satisfied (n=173)

41.1

58.1

53.8

47.9

47.9

51.4

45.8

Neither satisfied nor dissatisfied (n=81)

37.9

61.1

57.9

51.3

51.3

55.0

40.9

Somewhat dissatisfied (n=139)

35.8

63.6

60.9

52.7

52.8

56.0

38.3

Very dissatisfied (n=89)

33.0

66.7

67.2

60.3

58.8

61.7

32.2

* Table presents mean scores for individuals in each satisfaction with health rating group.  Differences were tested with ANOVA and non-parametric test for trend.  All were significant p<.001.


Disclosure:

P. P. Katz,
None;

S. Pedro,
None;

K. Michaud,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/test-of-the-nih-patient-reported-outcomes-measurement-information-system-promis-29-item-profile-in-a-large-cohort-of-rheumatic-disease-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology